Inhibition of Myocardin-related Transcription Factor A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle
American Journal of Respiratory Cell and Molecular Biology · 2025
DOI: 10.1165/rcmb.2023-0465oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2025. Verfasst von Mark F Rzepka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Labatt Family Heart Center Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Ventricular Remodeling, Heart Ventricles, Trans-Activators, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Right ventricular (RV) fibrosis is associated with RV dysfunction in a variety of RV pressure-loading conditions in which RV mechanical stress is increased, but the underlying mechanisms driving RV fibrosis are incompletely understood. In pulmonary and cardiovascular diseases characterized by elevated mechanical stress and transforming growth factor-β1 signaling, myocardin-related transcription factor A (MRTF-A) is a mechanosensitive protein critical to driving myofibroblast transition and fibrosis. In this study, we investigated whether MRTF-A inhibition improves RV profibrotic remodeling and function in response to a pulmonary artery banding (PAB) model of RV pressure loading. Rats were assigned into either sham or PAB groups. MRTF-A inhibitor CCG-1423 was administered daily at 0.75 mg/kg in a subset of PAB animals. Echocardiography and pressure–volume hemodynamics were obtained at a terminal experiment 6 weeks later. RV myocardial samples were analyzed for fibrosis, cardiomyocyte hypertrophy, and profibrotic signaling. MRTF-A inhibition slightly reduced systolic dysfunction in PAB rats reflected by increased lateral tricuspid annulus peak systolic velocity, whereas diastolic function parameters were not significantly improved. RV remodeling was attenuated in PAB rats with MRTF-A inhibition, displaying reduced fibrosis. This was accompanied with a reduction in PAB-induced upregulation of Yes-associated protein (YAP) and its paralog transcriptional coactivator with PDZ-binding motif (TAZ). We also confirmed, using a second-generation MRTF-A inhibitor CCG-203971, that MRTF-A is critical in driving RV fibroblast expression of TAZ and markers of myofibroblast transition in response to transforming growth factor-β1 stress and RhoA activation. These studies identify RhoA, MRTF-A, and YAP/TAZ as interconnected regulators of profibrotic signaling in RV pressure loading and as potential targets to improve RV profibrotic remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Labatt Family Heart Center Toronto, Toronto, Ontario, Canada.
- Keenan Research Center for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
- Department of Surgery, St. Michael's Hospital and the University of Toronto, Toronto, Ontario, Canada; and.
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Rzepka, M. F., Raschzok, S., Lee, X. A., Yazaki, K., Dauz, J., Sun, M., Meister, T., Nghiem, L., Kabir, G., Desjardins, J. F., Kuebler, W. M., Kapus, A., Connelly, K. A., & Friedberg, M. K. (2025). Inhibition of Myocardin-related Transcription Factor A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2023-0465oc
Vancouver
Rzepka MF, Raschzok S, Lee XA, Yazaki K, Dauz J, Sun M, et al. Inhibition of Myocardin-related Transcription Factor A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle. American Journal of Respiratory Cell and Molecular Biology. 2025. doi:10.1165/rcmb.2023-0465oc
BibTeX
@article{Rzepka2025,
author = {Rzepka, Mark F and Raschzok, Sonja and Lee, Xavier A and Yazaki, Kana and Dauz, John and Sun, Mei and Meister, Theo and Nghiem, Linda and Kabir, Golam and Desjardins, Jean-Francois and Kuebler, Wolfgang M and Kapus, Andras and Connelly, Kim A and Friedberg, Mark K},
title = {Inhibition of Myocardin-related Transcription Factor A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2025},
doi = {10.1165/rcmb.2023-0465oc}
}
EUVIMED